NU17CE010196
Cooperative Agreement
Overview
Grant Description
Alabama's Overdose Data to Action-State Program - Application for the Centers for Disease Control and Prevention (CDC) Overdose Data to Action State (OD2A-S) grant will allow the Alabama (AL) Department of Public Health (ADPH) to continue and expand statewide efforts to combat the ongoing, nationwide opioid and stimulant crisis initiated with the current CDC funding Overdose Data to Action grant.
AL continues to experience a higher drug overdose death rate as compared to the United States as the overdose epidemic continues to evolve. The landscape of the drug overdoses in AL shifted to involve illicitly manufactured fentanyl and fentanyl analogs and polysubstance deaths involving both opioids and stimulants.
This funding would allow ADPH to collaborate closely with diverse multi-sector and multi-level surveillance and prevention partners to address this shift in landscape with opioid and stimulant related harms, use and misuse, fatal and non-fatal overdoses, and social determinants of health and health equity.
ADPH intends to improve surveillance and data reporting to engage in an ongoing analysis and dissemination of timely data on drug overdoses, emerging threats, and associated risk factors to key partners implementing prevention activities.
Surveillance strategies (1-3) will build and sustain an internal, statewide overdose dashboard, develop protocols and practices for detecting overdose outbreaks, rapidly report and submit emergency department data, and improve the collection and dissemination of AL's death data for surveillance of overdose.
Prevention strategies (6-9) will use data-driven evidence, program data, and evaluation data to drive opportunities to intervene and reduce health disparities and overdoses. Efforts will focus on enhancing clinician and health system engagement and capacity to ensure they are adequately equipped to contribute to prevention solutions, expand PDMP through interstate data sharing agreements and incorporate PDMP into electronic health records and pharmacy management systems, increase public health and public safety partnerships through increased information tracking and sharing and link at-risk incarcerated individuals to appropriate care and resources prior to release, implement and support evidence-based interventions while partnering with harm reduction organizations and peer support groups, reduce stigma toward people who use drugs, provide harm reduction services and peer support to those groups who are disproportionately affected by overdose and/or underserved, and initiating community-based linkage to care.
By meeting these grant strategies, ADPH's goals are to: (1) increase timely, comprehensive, and actionable data, including toxicology testing for both fatal and non-fatal overdoses; (2) increase utilization of data to inform and tailor prevention strategies, with emphasis on reaching groups disproportionately affected by the drug overdose in AL; (3) decrease stigma related to substance use and overdose; (4) decrease health disparities related to access to and receipt of care, especially among persons who use drugs and those previously underserved by overdose prevention programs and healthcare systems; and (5) decrease overall fatal and nonfatal overdose deaths related to opioid and stimulant use.
AL continues to experience a higher drug overdose death rate as compared to the United States as the overdose epidemic continues to evolve. The landscape of the drug overdoses in AL shifted to involve illicitly manufactured fentanyl and fentanyl analogs and polysubstance deaths involving both opioids and stimulants.
This funding would allow ADPH to collaborate closely with diverse multi-sector and multi-level surveillance and prevention partners to address this shift in landscape with opioid and stimulant related harms, use and misuse, fatal and non-fatal overdoses, and social determinants of health and health equity.
ADPH intends to improve surveillance and data reporting to engage in an ongoing analysis and dissemination of timely data on drug overdoses, emerging threats, and associated risk factors to key partners implementing prevention activities.
Surveillance strategies (1-3) will build and sustain an internal, statewide overdose dashboard, develop protocols and practices for detecting overdose outbreaks, rapidly report and submit emergency department data, and improve the collection and dissemination of AL's death data for surveillance of overdose.
Prevention strategies (6-9) will use data-driven evidence, program data, and evaluation data to drive opportunities to intervene and reduce health disparities and overdoses. Efforts will focus on enhancing clinician and health system engagement and capacity to ensure they are adequately equipped to contribute to prevention solutions, expand PDMP through interstate data sharing agreements and incorporate PDMP into electronic health records and pharmacy management systems, increase public health and public safety partnerships through increased information tracking and sharing and link at-risk incarcerated individuals to appropriate care and resources prior to release, implement and support evidence-based interventions while partnering with harm reduction organizations and peer support groups, reduce stigma toward people who use drugs, provide harm reduction services and peer support to those groups who are disproportionately affected by overdose and/or underserved, and initiating community-based linkage to care.
By meeting these grant strategies, ADPH's goals are to: (1) increase timely, comprehensive, and actionable data, including toxicology testing for both fatal and non-fatal overdoses; (2) increase utilization of data to inform and tailor prevention strategies, with emphasis on reaching groups disproportionately affected by the drug overdose in AL; (3) decrease stigma related to substance use and overdose; (4) decrease health disparities related to access to and receipt of care, especially among persons who use drugs and those previously underserved by overdose prevention programs and healthcare systems; and (5) decrease overall fatal and nonfatal overdose deaths related to opioid and stimulant use.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Funding Agency
Place of Performance
Alabama
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 103% from $3,519,072 to $7,138,144.
Alabama Department Of Public Health was awarded
ALABAMA OD2A-S Grant: Combating Opioid Crisis
Cooperative Agreement NU17CE010196
worth $7,138,144
from Injury Center in September 2023 with work to be completed primarily in Alabama United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.136 Injury Prevention and Control Research and State and Community Based Programs.
The Cooperative Agreement was awarded through grant opportunity Overdose Data to Action in States.
Status
(Ongoing)
Last Modified 11/7/24
Period of Performance
9/1/23
Start Date
8/31/28
End Date
Funding Split
$7.1M
Federal Obligation
$0.0
Non-Federal Obligation
$7.1M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for NU17CE010196
Transaction History
Modifications to NU17CE010196
Additional Detail
Award ID FAIN
NU17CE010196
SAI Number
NU17CE010196-881248268
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75CDC1 CDC OFFICE OF FINANCIAL RESOURCES
Funding Office
75CUH0 CDC NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL
Awardee UEI
WDVJK7FUB8A6
Awardee CAGE
1KKY9
Performance District
AL-90
Senators
Tommy Tuberville
Katie Britt
Katie Britt
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
Injury Prevention and Control, Centers for Disease Control and Prevention, Health and Human Services (075-0952) | Health care services | Grants, subsidies, and contributions (41.0) | $3,519,072 | 100% |
Modified: 11/7/24